Mounjaro (tirzepatide) uniquely targets both GLP-1 and GIP receptors, potentially offering more substantial weight reduction and improved glycemic control compared to other GLP-1RAs that only target the GLP-1 receptor, such as Ozempic (semaglutide)
Bacterial byproducts from the small intestine enter the bloodstream and can drive systemic symptoms including fatigue, brain fog, joint pain, rosacea, and mood disturbances
Published meta-analyses generally agree that intravenous ALA is approximately 50% more effective than the oral form [107]
We frequently offer promotions and discounts, so ask about our current deals
But for wellness-focused high performers, the reality has been less appealing
More research is needed before alpha-lipoic acid can be recommended for treatment